The present disclosure provides methods of treatment with cells having a vaccine (e.g., gp96-lg) and cells having a T-cell co-stimulatory molecule.L'invention concerne des méthodes de traitement avec des cellules comportant un vaccin (par exemple, gp96-lg) et des cellules comportant une molécule co-stimulatrice de lymphocytes T.